Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

Brahm H. Segal(Roswell Park Comprehensive Cancer Center), B.E. de Pauw(Radboud University Nijmegen), Thierry Calandra(University of Lausanne), David A. Stevens(Stanford University), John R. Perfect(Duke University), Catherine Cordonnier(Université Paris-Est Créteil), William E. Dismukes(University of Alabama), L. Joseph Wheat(Indiana Department of Natural Resources), Raoul Herbrecht(Institut de Cancérologie Strasbourg), Eric J. Bow(CancerCare Manitoba), Jack D. Sobel(Wayne State University), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Dimitrios P. Kontoyiannis(University of Alabama at Birmingham), Luis Ostrosky‐Zeichner(The University of Texas Health Science Center), B. Dupont(Délégation Paris 5), John E. Bennett(National Institute of Allergy and Infectious Diseases), Bart Jan Kullberg(Radboud University Nijmegen), Johan Maertens(Unknown), Nikolaos G. Almyroudis(Roswell Park Comprehensive Cancer Center), Jacques Billé(University Hospital of Lausanne), Wolfgang Graninger(University of Vienna), Thomas F. Patterson(The University of Texas at San Antonio Health Science Center), Claudio Viscoli(Radboud University Nijmegen), M. A. Viviani, Peter G. Pappas(University of Alabama at Birmingham), John R. Graybill(Office of Infectious Diseases), Lindsey R. Baden(Brigham and Women's Hospital), John R. Wingard(University of Florida Health), Carol A. Kauffman(University of Michigan), Thomas J. Walsh(Innovative Clinical Research)
Clinical Infectious Diseases
July 18, 2008
Cited by 469


Related Papers